154 related articles for article (PubMed ID: 19476263)
1. Optimizing outcomes with bevacizumab by better targeting patients and tumors.
DeMichele A; Fox KR
Oncology (Williston Park); 2009 Apr; 23(4):339-40. PubMed ID: 19476263
[No Abstract] [Full Text] [Related]
2. Bevacizumab in breast cancer: the best is yet to come?
Puhalla S; Brufsky A
Oncology (Williston Park); 2009 Apr; 23(4):332, 335. PubMed ID: 19476262
[No Abstract] [Full Text] [Related]
3. Bevacizumab in the treatment of metastatic breast cancer.
Traina TA
Oncology (Williston Park); 2009 Apr; 23(4):327-32. PubMed ID: 19476261
[TBL] [Abstract][Full Text] [Related]
4. Bevacizumab for the first-line treatment of human epidermal growth factor receptor 2-negative advanced breast cancer.
Damasceno M
Curr Opin Oncol; 2011 Apr; 23 Suppl():S3-9. PubMed ID: 21490481
[TBL] [Abstract][Full Text] [Related]
5. Avastin withdrawal symptoms.
Lynce F; Swain SM
Expert Opin Pharmacother; 2012 Feb; 13(3):293-8. PubMed ID: 22263961
[No Abstract] [Full Text] [Related]
6. Success of bevacizumab trials raises questions for future studies.
Tuma RS
J Natl Cancer Inst; 2005 Jul; 97(13):950-1. PubMed ID: 15998941
[No Abstract] [Full Text] [Related]
7. Bevacizumab-induced cardiovascular events: a consequence of cholesterol emboli syndrome?
Mir O; Mouthon L; Alexandre J; Mallion JM; Deray G; Guillevin L; Goldwasser F
J Natl Cancer Inst; 2007 Jan; 99(1):85-6. PubMed ID: 17202119
[No Abstract] [Full Text] [Related]
8. Anti-angiogenic therapies in metastatic breast cancer-an unfulfilled dream.
Buzdar AU
Lancet Oncol; 2011 Apr; 12(4):316-8. PubMed ID: 21429798
[No Abstract] [Full Text] [Related]
9. Bevacizumab and recurrent malignant gliomas: a European perspective.
Wick W; Weller M; van den Bent M; Stupp R
J Clin Oncol; 2010 Apr; 28(12):e188-9; author reply e190-2. PubMed ID: 20159801
[No Abstract] [Full Text] [Related]
10. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.
Sandler A; Gray R; Perry MC; Brahmer J; Schiller JH; Dowlati A; Lilenbaum R; Johnson DH
N Engl J Med; 2006 Dec; 355(24):2542-50. PubMed ID: 17167137
[TBL] [Abstract][Full Text] [Related]
11. Avastin's uncertain future in breast cancer treatment.
Twombly R
J Natl Cancer Inst; 2011 Mar; 103(6):458-60. PubMed ID: 21393607
[No Abstract] [Full Text] [Related]
12. Bevacizumab and breast cancer: the E2100 outlier.
Fojo T; Wilkerson J
Lancet Oncol; 2010 Dec; 11(12):1117-9. PubMed ID: 21126685
[No Abstract] [Full Text] [Related]
13. Bevacizumab + sunitinib: microangiopathic haemolytic anaemia. A serious drug interaction between 2 cancer drugs.
Prescrire Int; 2009 Aug; 18(102):165. PubMed ID: 19746526
[No Abstract] [Full Text] [Related]
14. Bevacizumab for advanced breast cancer: all tied up with a RIBBON?
Burstein HJ
J Clin Oncol; 2011 Apr; 29(10):1232-5. PubMed ID: 21383305
[No Abstract] [Full Text] [Related]
15. Bevacizumab for advanced breast cancer.
Traina TA; Rugo HS; Dickler M
Hematol Oncol Clin North Am; 2007 Apr; 21(2):303-19. PubMed ID: 17512451
[TBL] [Abstract][Full Text] [Related]
16. Bevacizumab in kidney cancer: new indication. Premature approval of this indication.
Prescrire Int; 2009 Feb; 18(99):10. PubMed ID: 19382401
[TBL] [Abstract][Full Text] [Related]
17. From theoretical synergy to clinical supra-additive toxicity.
Soria JC; Massard C; Izzedine H
J Clin Oncol; 2009 Mar; 27(9):1359-61. PubMed ID: 19224836
[No Abstract] [Full Text] [Related]
18. The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: clinical experience with anti-angiogenic agents, focusing on bevacizumab.
Marty M; Pivot X
Eur J Cancer; 2008 May; 44(7):912-20. PubMed ID: 18396037
[TBL] [Abstract][Full Text] [Related]
19. [Angiogenesis and breast cancer].
Bachelot T; Ray-Coquard I; Cassier P; Blay JY
Bull Cancer; 2007 Jul; 94 Spec No():S203-10. PubMed ID: 17846006
[TBL] [Abstract][Full Text] [Related]
20. Role of bevacizumab for the treatment of non-small-cell lung cancer.
Ramalingam S; Belani CP
Future Oncol; 2007 Apr; 3(2):131-9. PubMed ID: 17381412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
